安進製藥股份有限公司

  • About Us
    • Company Overview
    • History and Milestones
    • Company Strategy
    • Core Value
    • Management Team
    • External Consultants
    • Company organization
    • Awards & Recognition
    • Contact Us
  • R&D Pipeline
    • Product Pipeline
    • AJ201
    • AJ302
    • AJ303
  • Functional Ingredients
    • Frocurmin®
    • Mincurnion®
  • For Investors
    • Financial information
    • Corporate governance
    • Shareholder
  • Latest News
    • Material Information
    • Events
    • News
  • Sustainability
    • Social Good
    • Interested Parties
    • Human Rights Policy
    • Health & Safety
  • Career
    • Company Benefits
    • Environmental Facilities
    • Join Us
  • Language
    • 繁體中文
    • English
  • Home
  • About Us
    • Company Overview
    • History and Milestones
    • Company Strategy
    • Core Value
    • Management Team
    • External Consultants
    • Company organization
    • Awards & Recognition
  • R&D Pipeline
    • Product Pipeline
    • AJ201
    • AJ302
    • AJ303
  • Functional Ingredients
    • Frocurmin®
    • Mincurnion®
  • For Investors
    • Financial information
    • Corporate governance
    • Shareholder
  • Latest News
    • Material Information
    • Events
    • News
  • Sustainability
    • Social Good
    • Interested Parties
    • Human Rights Policy
    • Health & Safety
  • Company Benefits
    • Company Benefits
    • Environmental Facilities
    • Join Us
  • Home
  • For Investors
  • Corporate governance
  • Board of Directors Members
  • Corporate governance

    • Financial information
      • Financial information
      • Revenue Reports
    • Corporate governance
      • Board of Directors
      • Board of Directors Members
      • Functional Committees
      • Internal Audit
      • Integrity Management
      • Information and Communication Security
      • Intellectual Property Rights
      • Major Internal Policies
    • Shareholder
      • Major Shareholders
      • Investor Relations and Media Contact
      • Annual General Meeting of Shareholders
      • Investor Conference / Press Conference
      • Market Observation Post System (MOPS)

    Board of Directors Members

    • Read More
      CEO & President of the Board
      Wendy Huang, Ph.D.
    • Read More
      Director
      Taiwania Capital Buffalo II Biotech Venture Capital Limited Partnership
      Representative:Chen, Yi-Ying
    • Read More
      Director
      Fubon Financial Holding Venture Capital
      Representative:Willy Huang
    • Read More
      Director
      President International Development Corp.
      Representative:Dean Chuang
    • Read More
      Director
      Orient EuroPharma CO., Ltd.
      Representative:Calvin Tsai
    • Read More
      Independent Director
      Su, Yu-Hui
    • Read More
      Independent Director
      Chang, Chen-Wu
    • Read More
      Independent Director
      Kang, Chao-Chou
    • Read More
      Independent Director
      Liu, Ching-Ping
    • About Us
    • R&D Pipeline
    • Functional Ingredients
    • For Investors
    • Latest News
    • Sustainability
    • Career
    • Address:16F.-6, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011 , Taiwan
    • Phone:+886 2 2365-5677
    • Fax:+886 2 2365-8022
    © 2026 AnnJi Pharmaceutical Co., Ltd. All Rights Reserved.
    Designed by JDDT